According to Tech.eu’s recent report, Ireland secured the ninth position in Europe for health tech investment in 2025, highlighting a robust funding landscape across various sectors including biotech and AI-enabled healthcare.
The report, titled *European Tech 2025 – The Big Picture*, reveals that the UK led the market with significant investments totaling €2.5 billion, particularly in AI drug discovery and surgical robotics. Switzerland and Finland followed, with investments exceeding €1 billion and €881 million, respectively. Ireland's health tech investment surpassed €305 million, trailing behind Sweden and France but outperforming Denmark.
Tech.eu noted that the investment landscape was characterized by substantial growth rounds, with Series A and B deals indicating a strong interest in early-stage clinical developments and companies poised for commercialization. Noteworthy is Oura Health, which raised over $900 million to enhance its AI capabilities and expand its product offerings. Isomorphic Labs, a spin-off from DeepMind, also made headlines by securing $600 million to innovate drug discovery through machine learning technologies.
The findings underscore a significant momentum in the health tech sector, suggesting that investors are increasingly backing companies that leverage advanced technologies to improve healthcare outcomes. This trend could lead to accelerated advancements in digital health and AI applications, potentially transforming patient care and treatment methodologies in the near future.